Henry Schein, Inc.
NASDAQ:HSIC · NASDAQ Global Select
-$1.24 today
Vol 1.81M · Avg 1.39M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+11.17%
Period High
$83.35
Period Low
$62.03
Latest
$79.92
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector

DaVita Inc.
NYSE:DVA
$13.52B

Molina Healthcare, Inc.
NYSE:MOH
$10.19B

Globus Medical, Inc.
NYSE:GMED
$10.17B

Masimo Corporation
NASDAQ:MASI
$9.42B

Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.13B

Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.70B

AptarGroup, Inc.
NYSE:ATR
$7.66B

Avantor, Inc.
NYSE:AVTR
$6.46B

Grifols, S.A.
NASDAQ:GRFS
$6.31B
What is the latest HSIC filing?
The latest filing shown is 11-K dated Jun 18, 2026.
How many recent filings does HSIC have?
Intrinsic Alpha currently shows 20 recent filings for HSIC.
Explore More
Continue the stock analysis
Jump to another research area for this company.